The Paras Healthcare IPO is an upcoming public issue that investors may be tracking for its price band, issue size, subscription status, and tentative listing date. The IPO combines a fresh issue of shares with an offer for sale (OFS), making it important to understand how the proceeds will be used and what existing shareholders may sell.
In this guide, we cover the Paras Healthcare IPO date 2026, price band, lot size, Grey Market Premium (GMP), allotment timeline, and key points investors should review before making an investment decision.
Paras Healthcare IPO Details
Paras Healthcare IPO is a book-building issue worth ₹1,450 crore. It comprises a fresh issue of 72.15 lakh shares aggregating to ₹500 crore and an offer for sale of approximately 1.37 crore shares worth ₹950 crore.
Here are the key Paras Healthcare IPO details:
| IPO Particulars | Details |
| Issue Size | ₹1,450 crore |
| Fresh Issue | ₹500 crore |
| Offer for Sale | ₹950 crore |
| IPO Open Date | October 21, 2026 |
| IPO Close Date | October 23, 2026 |
| Price Band | ₹660–₹693 per share |
| Face Value | ₹1 per share |
| Lot Size | 21 shares |
| Minimum Retail Investment | ₹14,553 |
| Allotment Date | October 26, 2026 (tentative) |
| Refund Initiation | October 27, 2026 (tentative) |
| Share Credit | October 27, 2026 (tentative) |
| Listing Date | October 28, 2026 (tentative) |
| Listing Exchanges | NSE and BSE |
Dates and issue details are based on the supplied IPO information and should be verified against official exchange filings and the final prospectus.
About Paras Healthcare
Paras Healthcare operates in the healthcare sector, where hospitals and medical services play an important role in delivering specialised treatment and patient care. Investors researching the company should examine its hospital network, geographical presence, bed capacity, speciality mix, occupancy levels, revenue growth, profitability, debt, and expansion plans.
Before evaluating the IPO, read the company’s offer documents to understand its business model, financial performance, competitive position, risk factors, and intended use of the fresh issue proceeds.
Paras Healthcare IPO Price Band 2026 and Lot Size
The Paras Healthcare IPO price band 2026 is ₹660 to ₹693 per share. Investors can apply for a minimum of 21 shares and in multiples of the lot size thereafter.
At the upper price band of ₹693, the minimum retail application amount is ₹14,553 for one lot of 21 shares. The actual amount payable and application rules should be checked with your broker before placing a bid.
The IPO has different application thresholds for retail investors and high-net-worth individual (HNI) categories. Investors should confirm the applicable category limits and reservation details in the official offer documents.
Paras Healthcare IPO GMP Today
The Paras Healthcare IPO GMP today refers to the unofficial premium at which IPO shares are reportedly traded in the grey market before listing. GMP is not an official exchange price and may fluctuate considerably.
No verified live GMP figure has been provided for this article. Readers should check an up-to-date source before referring to any reported premium. Even if the GMP is positive, it does not guarantee listing gains or future returns.
| GMP Date | GMP | Est. Listing Price | Est. Profit/Loss per Lot | Trend |
| 19-Oct 10:37 | ₹92 (13.28%) – | ₹785 | ₹1,932 | Stable |
| 18-Oct 23:37 | ₹92 (13.28%) ▼ | ₹785 | ₹1,932 | Stable |
| 17-Oct 23:37 | ₹96 (13.85%) ▲ | ₹789 | ₹2,016 | Stable |
| 16-Oct 23:37 | ₹95 (13.71%) – | ₹788 | ₹1,995 | Stable |
| 15-Oct 23:37 | ₹95 (13.71%) ▲ | ₹788 | ₹1,995 | Stable |
| 14-Oct 23:37 | ₹83 (0.00%) – | ₹83 | ₹0 | Initial |
Important: GMP is unofficial and may change. It should not be used as the sole basis for an investment decision.
Paras Healthcare IPO Subscription Status
The Paras Healthcare IPO subscription status shows the demand received from different investor categories during the bidding period. These categories generally include Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and retail individual investors.
According to the supplied issue information, the reservation is not more than 75% for QIBs, not less than 15% for NIIs, and not less than 10% for retail investors. Investors should verify the final allocation structure in the official documents.
Subscription figures can change throughout the three-day bidding period. Check the latest available data from reliable exchange or registrar sources rather than relying on outdated figures.
Paras Healthcare IPO Allotment Status 2026
The Paras Healthcare IPO allotment status 2026 is expected to be finalised on October 26, 2026, subject to the published timetable.
After the allotment is finalised, applicants can check their status through the official registrar’s website or relevant exchange-linked services. Keep your PAN, application number, or demat details available as required by the platform.
Refunds for unsuccessful or partially allotted applications are tentatively scheduled to begin on October 27, 2026. Shares are also expected to be credited to demat accounts around that date, subject to the final timetable.
Paras Healthcare IPO Listing Date 2026
The Paras Healthcare IPO listing date 2026 is tentatively scheduled for October 28, 2026, on the NSE and BSE.
The actual listing price may differ from the IPO issue price because of market conditions, investor demand, company fundamentals, and broader sector sentiment. A scheduled listing date does not imply a particular price performance.
Paras Healthcare IPO Review 2026: Is It Worth Applying?
Investors asking whether the Paras Healthcare IPO is worth applying should consider more than the price band or grey market premium. Review the following factors before making a decision:
- Financial performance: Examine revenue, profit, margins, cash flow, and debt over multiple years.
- Valuation: Compare the IPO valuation with listed healthcare and hospital companies using suitable financial metrics.
- Use of proceeds: Understand how the ₹500 crore fresh issue component is intended to be used.
- Offer for sale: Review the selling shareholders and the reasons for the ₹950 crore OFS component.
- Business risks: Evaluate competition, regulatory requirements, operating costs, staffing needs, and expansion risks.
- Market conditions: Consider overall equity-market volatility and your own investment horizon and risk tolerance.
The OFS component represents shares sold by existing shareholders; those proceeds generally go to the selling shareholders rather than the company. The fresh issue, by contrast, raises new capital for the company, subject to the stated purposes in the offer documents.
There is no guaranteed outcome from an IPO investment. Read the Red Herring Prospectus (RHP), assess the valuation independently, and consult a registered financial adviser if needed.
Paras Healthcare IPO Latest News
For Paras Healthcare IPO latest news, monitor official announcements about the issue timetable, price band, subscription figures, allotment, and listing. Changes to the schedule or issue terms should be confirmed through the company’s filings, the NSE, BSE, or the official registrar.
Conclusion
The Paras Healthcare IPO brings together a ₹500 crore fresh issue and a ₹950 crore offer for sale, with a stated price band of ₹660–₹693 per share. Investors should review the company’s financials, valuation, business risks, and official offer documents before deciding whether the issue fits their financial goals.
Track verified updates on 4R Investments and use reliable sources for current GMP, subscription, allotment, and listing information.
Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice or a recommendation to apply for the IPO. Investments in securities are subject to market risks. Please read all relevant offer documents carefully before investing.
Invest with 4R Investments
Stay updated with IPOs, stock market news, investment opportunities and market insights with 4R Investments. We provide investor-focused assistance, IPO updates and support for demat and trading services to help investors make more informed decisions.
Looking for guidance on your investment journey? At 4R Investments, we help investors explore market opportunities and make informed decisions with research-based insights and personalized support.
Connect with 4R Investments today to learn more about investment and market-related opportunities.
Invest with 4R Investments
Planning to invest in upcoming IPOs? 4R Investments helps you stay updated with the latest IPO news, GMP trends, and expert investment insights.
Open your FREE Demat Account with 4R Investments and begin your investment journey with expert guidance and seamless access to the stock market.
⚠️ Disclaimer
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. This is only for informational purposes.
Angel One Ltd. is just acting as the distributor of the IPO. Investors are requested to do their due diligence before investing in any IPO. Investor grievance redressal mechanism of exchange would not be available for applying in IPO
📍 Registration Details
Angel One Limited (formerly known as Angel Broking Limited), Registered Office: 601, 6th Floor, Ackruti Star, Central Road, MIDC, Andheri East, Mumbai – 400093.
Tel: 080-47480048
CIN: L67120MH1996PLC101709
SEBI Regn. No.: INZ000161534
Compliance Officer: Mr. Bineet Jha
Tel: (022) 39413940
Email: compliance@angelbroking.com
📞 Contact 4R Investments
📍 3-1-309/310, Tara Kaushalya Nivas, Nimboliadda, Kachiguda, Hyderabad – 500027
📞 6300169336
📧 4rdigitalmarketingteam@gmail.com
🌐 https://4rinvestments.in/